Zacks' 7 Best Stocks for July, 2013
FREE Report for Zacks.com
Visitors Only

They're hand-picked from the list of Zacks Rank #1 Strong Buys. Our experts predict that their prices will jump the soonest.

Today, you can see them free.

Close This Panel X

Are you a new Zacks Member or a visitor to Zacks.com?

Recent Quotes

No Recent Quote currently available

My Portfolio

My Portfolio Tracker

One of the most important steps you can take today is to set up your portfolio tracker on Zacks.com. Once you do, you'll be notified of major events affecting your stocks and/or funds with daily email alerts. Set yours up today.

More Zacks Resources

Zacks Rank Home - Evaluate your stocks and use the Zacks Rank to eliminate the losers and keep the winners.

Mutual Fund Rank Home - Evaluate your funds with the Mutual Fund Rank for both your personal and retirement funds.

Stock/Mutual Fund Screening - Find better stocks and mutual funds. The ones most likely to beat the market and provide a positive return.

My Portfolio - Track your Portfolio and find out where your stocks/mutual funds stack up with the Zacks Rank.

Zacks #1 Stocks on the Move 06/19/2013

Company Name Symbol %Change
SONIC FOUNDR SOFO
4.40%
SUPPORT.COM SPRT
3.75%
UNISYS UIS
3.31%
SHORETEL INC SHOR
3.22%
GREEN MTN CO GMCR
3.13%

IDEX Corp Easily Beats

by Zacks Equity Research

February 07, 2012 | Comments : 0 Recommended this article: (0)
IEX

This page is temporarily not available.  Please check later as it should be available shortly. If you have any questions, please email customer support at support@zacks.com or call 800-767-3771 ext.  9339.

IDEX Corporation (IEX - Snapshot Report) has posted adjusted earnings per share (excluding the effect of the inventory charge) of 65 cents in the fourth quarter of 2011 compared with 71 cents in the previous quarter and 54 cents in the year-ago quarter. The results surpassed the Zacks Consensus Estimate of 63 cents.

IDEX Corporation designs, manufactures and markets a broad range of fluid handling and industrial products serving a diverse range of customers.

Sales improved 19% from the year-ago quarter to $481 million and were in line with the Zacks Consensus Estimate. Organic growth was 7% in the quarter. New orders were $447 million, up 9% from the year-earlier quarter.

Net income came in at $47.4 million or $0.57 per share compared to a net income of $41.5 million or $0.50 per share in the year-ago quarter.

On a segmental basis, Fluid & Metering Technologies generated revenues of $214 million, up 8% from the year-ago quarter.

Revenue from Health & Science Technologies was $168 million, up 51% from the year-ago quarter. Organic growth was 7% and acquisitions contributed 44%.

Dispensing Equipment generated revenues of $24 million, down 1% from the year-ago quarter. Revenues from Fire & Safety/Diversified Products were $76 million, up 6% from the year-ago quarter.

Operating margin moved up to 17.8% from 17.4% in the year-ago quarter but declined from 18.3% in the previous quarter.

During the quarter, IDEX Corp. generated cash of $41.6 million from operations and used $7.2 million for capital expenditures.

For 2011, IDEX Corp. reported sales of $1.8 billion, up 22% year over year. Organic growth was 9%, acquisition related growth of 11% and a positive impact of 2% from foreign currency translation. Orders increased 18% year over year.

EPS came in at $2.32, compared to $1.90 in 2010. Adjusted EPS came in at $2.56, up by $0.57 from 2010.

Guidance

Management stated that the external market remains volatile as the company continues to see a shift to shorter order cycle patterns. The company expects to see mid-single digit organic growth in 2012 and will focus on emerging regions and high growth markets.

IDEX Corp. expects an EPS of 62 to 64 cents for the first quarter of 2012. For full 2012, EPS is projected around $2.74 – $2.82.

Email Print Share Rate Pos Rate Neg

Read/Post Comments (0) | Recommended this article (0)

Please login to Zacks.com or register to post a comment.

Zacks Research is Reported On:

Zacks Investment Research

is an A+ Rated BBB

Accredited Business.